Chiung-Yao Huang

Title: Chiung-Yao Huang: Innovator in Pharmaceutical Research

Introduction

Chiung-Yao Huang is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target cancer and inflammatory diseases. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.

Latest Patents

Huang's latest patents include innovative uses of sulfur-containing compounds. The first patent focuses on the pharmaceutical applications of these compounds in inhibiting activities related to cancer metastasis and growth, specifically targeting lung cancer. The second patent involves the use of diterpene excavatolide B, derived from coral, for treating diseases associated with inducible nitric oxide synthase, cyclooxygenase-2, and matrix metalloproteinase. This invention also addresses conditions related to TNF-α and IL-6 over-expression.

Career Highlights

Chiung-Yao Huang is affiliated with the National Sun Yat-Sen University of Kaohsiung, where he conducts his research. His academic background and ongoing research efforts contribute to advancements in pharmaceutical sciences. His work is characterized by a commitment to exploring novel therapeutic approaches.

Collaborations

Huang collaborates with esteemed colleagues, including Jyh-Horng Sheu and Ning-Sun Yang. These partnerships enhance the scope and depth of his research, fostering innovation in the pharmaceutical field.

Conclusion

Chiung-Yao Huang's contributions to pharmaceutical research exemplify the importance of innovation in addressing critical health challenges. His patents reflect a dedication to developing effective treatments for cancer and inflammatory diseases.